Increasing the expression of these miRNAs in ovarian cancer cells decreased the expression level of the EZRIN protein, suggesting that the inhibition of EZRIN through miR-183 and miR-22 as tumor suppressors plays a role in inhibiting ovarian cancer metastasis. Here, EZR is linked to ovarian cancer.